The Corporate Counsel will draft, review, and negotiate a wide range of clinical, commercial, and research-related agreements. They will also contribute to the development of contract templates and standardized workflows to mitigate organizational risk.
The Director will establish and lead the internal Statistical Programming function, overseeing infrastructure, team building, and process development. They will serve as the lead programmer for CNS clinical trials and manage regulatory submission activities including BLA and NDA filings.
Establish and manage a risk-based quality strategy and audit program for clinical development and pharmacovigilance activities. Lead inspection readiness for global health authorities and oversee the quality management system, including SOPs and CAPAs.
